PortfoliosLab logo

Arrowhead Pharmaceuticals, Inc. (ARWR)

Equity · Currency in USD · Last updated Jan 31, 2023

Company Info

ISINUS04280A1007
CUSIP04280A100
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$33.61
Year Range$27.79 - $55.10
EMA (50)$34.42
EMA (200)$38.10
Average Volume$1.00M
Market Capitalization$3.83B

ARWRShare Price Chart


Loading data...

ARWRPerformance

The chart shows the growth of $10,000 invested in Arrowhead Pharmaceuticals, Inc. in Aug 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $61,630 for a total return of roughly 516.30%. All prices are adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2023
-24.98%
-3.30%
ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ARWRCompare to other instruments

Search for stocks, ETFs, and funds to compare with ARWR

Arrowhead Pharmaceuticals, Inc.

Popular comparisons: ARWR vs. PODD

ARWRReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-17.95%4.64%
YTD-17.95%4.64%
6M-21.75%-2.72%
1Y-33.56%-9.34%
5Y40.29%7.33%
10Y32.93%10.39%

ARWRMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202220.79%-6.63%-16.77%5.33%-7.50%25.96%

ARWRSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Arrowhead Pharmaceuticals, Inc. Sharpe ratio is -0.44. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20SeptemberOctoberNovemberDecember2023
-0.44
-0.29
ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ARWRDividend History


Arrowhead Pharmaceuticals, Inc. doesn't pay dividends

ARWRDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%SeptemberOctoberNovemberDecember2023
-63.21%
-16.24%
ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ARWRWorst Drawdowns

The table below shows the maximum drawdowns of the Arrowhead Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Arrowhead Pharmaceuticals, Inc. is 95.33%, recorded on Dec 16, 2016. It took 619 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.33%Mar 11, 2014701Dec 16, 2016619Jun 6, 20191320
-90.86%Jun 7, 2010726Apr 24, 2013202Feb 11, 2014928
-71.84%Dec 2, 201974Mar 18, 2020186Dec 10, 2020260
-69.28%Feb 8, 2021343Jun 16, 2022
-27.19%Mar 24, 20103Mar 26, 20102Mar 30, 20105
-25%Jan 26, 201024Mar 1, 201015Mar 22, 201039
-22.66%Aug 30, 201920Sep 27, 201914Oct 17, 201934
-19.35%Apr 30, 20105May 6, 201019Jun 3, 201024
-14.92%Dec 24, 20207Jan 5, 202122Feb 5, 202129
-13.41%Feb 24, 20145Feb 28, 20143Mar 5, 20148

ARWRVolatility Chart

Current Arrowhead Pharmaceuticals, Inc. volatility is 44.88%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%SeptemberOctoberNovemberDecember2023
44.88%
18.51%
ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (^GSPC)